Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for global professionals · Saturday, August 18, 2018 · 459,099,848 Articles · 3+ Million Readers

New Research: Key Drivers of Growth for Great Plains Energy, Flowers Foods, Hasbro, Acadia Healthcare, DXC Technology, and Alnylam Pharmaceuticals — Factors of Influence, Major Initiatives and Sustained Production

NEW YORK, Nov. 17, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Great Plains Energy Inc (NYSE:GXP), Flowers Foods, Inc. (NYSE:FLO), Hasbro, Inc. (NASDAQ:HAS), Acadia Healthcare Company, Inc. (NASDAQ:ACHC), DXC Technology Company. (NYSE:DXC), and Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

/EIN News/ -- Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

GXP DOWNLOAD: http://Fundamental-Markets.com/register/?so=GXP
FLO DOWNLOAD:
http://Fundamental-Markets.com/register/?so=FLO
HAS DOWNLOAD:
http://Fundamental-Markets.com/register/?so=HAS
ACHC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=ACHC
DXC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=DXC
ALNY DOWNLOAD:
http://Fundamental-Markets.com/register/?so=ALNY

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Great Plains Energy Inc (NYSE:GXP), Flowers Foods, Inc. (NYSE:FLO), Hasbro, Inc. (NASDAQ:HAS), Acadia Healthcare Company, Inc. (NASDAQ:ACHC), DXC Technology Company. (NYSE:DXC), and Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. All information in this release was accessed November 16th, 2017. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All amounts in millions (except per share amounts).

-----------------------------------------

GREAT PLAINS ENERGY INC (GXP) REPORT OVERVIEW

Great Plains Energy's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Great Plains Energy reported revenue of $857.20 vs $856.80 (up 0.05%) and diluted earnings per share $0.02 vs $0.86 (down 97.67%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Great Plains Energy reported revenue of $2,676.00 vs $2,502.20 (up 6.95%) and diluted earnings per share $1.61 vs $1.37 (up 17.52%). Great Plains Energy is expected to report earnings on February 22nd, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.13. The estimated EPS forecast for the next fiscal year is $1.82 and is expected to report on February 22nd, 2018.

To read the full Great Plains Energy Inc (GXP) report, download it here: http://Fundamental-Markets.com/register/?so=GXP

-----------------------------------------

FLOWERS FOODS, INC. (FLO) REPORT OVERVIEW

Flowers Foods' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Flowers Foods reported revenue of $932.82 vs $918.79 (up 1.53%) and diluted earnings per share -$0.16 vs $0.19. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Flowers Foods reported revenue of $3,926.89 vs $3,778.51 (up 3.93%) and diluted earnings per share $0.78 vs $0.89 (down 12.36%). Flowers Foods is expected to report earnings on February 12th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.16. The estimated EPS forecast for the next fiscal year is $0.92 and is expected to report on February 12th, 2018.

To read the full Flowers Foods, Inc. (FLO) report, download it here: http://Fundamental-Markets.com/register/?so=FLO

-----------------------------------------

HASBRO, INC. (HAS) REPORT OVERVIEW

Hasbro's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Hasbro reported revenue of $1,791.50 vs $1,679.76 (up 6.65%) and diluted earnings per share $2.09 vs $2.03 (up 2.96%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Hasbro reported revenue of $5,019.82 vs $4,447.51 (up 12.87%) and diluted earnings per share $4.34 vs $3.57 (up 21.57%). Hasbro is expected to report earnings on February 5th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $1.64. The estimated EPS forecast for the next fiscal year is $5.26 and is expected to report on February 5th, 2018.

To read the full Hasbro, Inc. (HAS) report, download it here: http://Fundamental-Markets.com/register/?so=HAS

-----------------------------------------

ACADIA HEALTHCARE COMPANY, INC. (ACHC) REPORT OVERVIEW

Acadia Healthcare's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Acadia Healthcare reported revenue of $716.71 vs $734.67 (down 2.44%) and diluted earnings per share $0.52 vs -$1.36. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Acadia Healthcare reported revenue of $2,810.91 vs $1,794.49 (up 56.64%) and diluted earnings per share $0.07 vs $1.64 (down 95.73%). Acadia Healthcare is expected to report earnings on February 22nd, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.59. The estimated EPS forecast for the next fiscal year is $2.50 and is expected to report on February 22nd, 2018.

To read the full Acadia Healthcare Company, Inc. (ACHC) report, download it here: http://Fundamental-Markets.com/register/?so=ACHC

-----------------------------------------

DXC TECHNOLOGY COMPANY. (DXC) REPORT OVERVIEW

DXC Technology's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, DXC Technology reported revenue of $6,163.00 vs $1,871.00 (up 229.4%) and diluted earnings per share $0.88 vs $0.10 (up 780%). For the twelve months ended March 31st, 2017 vs March 31st, 2016, DXC Technology reported revenue of $7,607.00 vs $7,106.00 (up 7.05%) and diluted earnings per share -$0.88 vs $1.78. DXC Technology is expected to report earnings on February 1st, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.81. The estimated EPS forecast for the next fiscal year is $8.43 and is expected to report on May 24th, 2018.

To read the full DXC Technology Company. (DXC) report, download it here: http://Fundamental-Markets.com/register/?so=DXC

-----------------------------------------

ALNYLAM PHARMACEUTICALS, INC. (ALNY) REPORT OVERVIEW

Alnylam Pharmaceuticals' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Alnylam Pharmaceuticals reported revenue of $17.10 vs $13.65 (up 25.24%) and diluted earnings per share -$1.34 vs -$1.21. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Alnylam Pharmaceuticals reported revenue of $47.16 vs $41.10 (up 14.75%) and diluted earnings per share -$4.79 vs -$3.45. Alnylam Pharmaceuticals is expected to report earnings on February 14th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$1.32. The estimated EPS forecast for the next fiscal year is -$5.83 and is expected to report on February 14th, 2018.

To read the full Alnylam Pharmaceuticals, Inc. (ALNY) report, download it here: http://Fundamental-Markets.com/register/?so=ALNY

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@fundamental-markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: andrew.duffie@fundamental-markets.com

2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@fundamental-markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Powered by EIN News